Literature DB >> 7478115

Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset.

S Schmidt1, A M Sharma, O Zilch, J Beige, M Walla-Friedel, D Ganten, A Distler, E Ritz.   

Abstract

A higher frequency of a variant of the angiotensinogen gene characterized by a transition in exon 2 causing a replacement of methionine by threonine (M235T) has recently been found in hypertensive individuals, but not all authors were able to confirm this observation. We examined (i) 219 patients with primary hypertension, (ii) 92 normotensive controls (spouses), and (iii) a sample of the general population (blood donors, n = 139). Analysis of genomic DNA was performed by PCR amplification and alleles were separated on agarose gels. In the general population and in normotensive spouses the respective frequencies of the T and M alleles were: general population: M = 0.6, T = 0.4; normotensive spouses: M = 0.59, T = 0.41. A significantly higher frequency of the 235T allele was found in hypertensive individuals with a family history of hypertension and an onset of hypertension before 50 years of age (spouses: 0.41 versus HT with age of onset < or = 50 years and family history of HT: 0.56; P = 0.01 by chi 2). In conclusion, the present study confirms the observation of a higher frequency of the 235T allele of the angiotensinogen gene in hypertension and identifies individuals with family history and early onset of hypertension as individuals at risk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478115

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  Renin-angiotensin system genes and exercise training-induced changes in sodium excretion in African American hypertensives.

Authors:  Jennifer M Jones; Jung-Jun Park; Jennifer Johnson; Dave Vizcaino; Brian Hand; Robert Ferrell; Matthew Weir; Thomas Dowling; Thomas Obisesan; Michael Brown
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

2.  Angiotensin converting enzyme I/D, angiotensinogen M235T and AT1-R A/C1166 gene polymorphisms in patients with acromegaly.

Authors:  Sebahat Turgut; Fulya Akın; Raziye Akcılar; Ceylan Ayada; Günfer Turgut
Journal:  Mol Biol Rep       Date:  2010-04-02       Impact factor: 2.316

3.  Haplotypes of angiotensinogen in essential hypertension.

Authors:  X Jeunemaitre; I Inoue; C Williams; A Charru; J Tichet; M Powers; A M Sharma; A P Gimenez-Roqueplo; A Hata; P Corvol; J M Lalouel
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 4.  Angiotensinogen variants and human hypertension.

Authors:  X Jeunemaitre; A P Gimenez-Roqueplo; J Célérier; P Corvol
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

5.  Effect of the angiotensinogen genotype on experimental hypertension in mice.

Authors:  Claudia Handtrack; Nada Cordasic; Bernd Klanke; Roland Veelken; Karl F Hilgers
Journal:  J Mol Med (Berl)       Date:  2007-03-02       Impact factor: 4.599

Review 6.  [Role of the angiotensinogen gene for essential hypertension].

Authors:  E Brand; J Ringel; A M Sharma
Journal:  Herz       Date:  2000-02       Impact factor: 1.740

7.  Polymorphisms of the insertion / deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data.

Authors:  Adrian Mondry; Marie Loh; Pengbo Liu; Ai-Ling Zhu; Mato Nagel
Journal:  BMC Nephrol       Date:  2005-01-11       Impact factor: 2.388

8.  Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: a case control study.

Authors:  Yee-How Say; King-Hwa Ling; Gnanasothie Duraisamy; Suzanne Isaac; Rozita Rosli
Journal:  BMC Cardiovasc Disord       Date:  2005-04-05       Impact factor: 2.298

9.  Simultaneous Genotyping of the rs4762 and rs699 Polymorphisms in Angiotensinogen Gene and Correlation with Iranian CAD Patients with Novel Hexa-primer ARMS-PCR.

Authors:  Mehri Khatami; Mohammad Mehdi Heidari; Mehdi Hadadzadeh; Barbara Scheiber-Mojdehkar; Morteza Bitaraf Sani; Massoud Houshmand
Journal:  Iran J Public Health       Date:  2017-06       Impact factor: 1.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.